Among cells expressing somewhat more ERK1, Blasco et al. indicate that lung tumor development driven by K-RasG12V is not impaired upon invalidation of a single isoform; however disruption of both ERK1 and ERK2 appears necessary to block tumor progression (Blasco et al., 2011). The gene discussed is MAPK1; the disease is neoplasm.